Amazon One Medical vs GoodRx
Amazon One Medical and GoodRx both sell orforglipron; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Amazon One Medical
Best for: oral orforglipron alongside the injectables
Visit Amazon One Medical →
If you are choosing between Amazon One Medical and GoodRx, price alone will not settle it. Both prescribe orforglipron, so moving from one to the other would not change your drug. Amazon One Medical leads our six-part score, 7.1 to 6.9.
Amazon One Medical vs GoodRx price
Amazon One Medical and GoodRx start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Orforglipron costs the same at both, $149 a month.
Medications and formats
Both sell orforglipron; only GoodRx lists tirzepatide.
On format they match: each offers brand-name pens.
Where each one treats patients
Amazon One Medical lists 50 states, and GoodRx lists 50 states.
They overlap in 50 states.
Pricing
Amazon One Medical
GoodRx
What each price covers
Amazon One Medical's price also covers the clinician visit and shipping, which GoodRx does not claim.
Amazon One Medical is silent on coaching.
GoodRx does not say what its price includes.
Amazon One Medical
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
In the price
Lab work
Charged on top
Coaching
Not stated
GoodRx
Inclusions not disclosed.
Where each one scores higher
Overall, Amazon One Medical scores 7.1 and GoodRx 6.9 out of 10.
Amazon One Medical is stronger on user experience (7.5 vs 5.0) and trust & safety (8.5 vs 6.0).
GoodRx is stronger on effectiveness (10.0 vs 8.0) and support (5.0 vs 4.0).
Value and accessibility are within half a point.
Amazon One Medical
7.1/10
GoodRx
6.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Amazon One Medical nor GoodRx has an FDA warning letter on record with us.
Features & Coverage
| Feature | Amazon One Medical | GoodRx |
|---|---|---|
| Starting Price | $149/mo | $149/mo |
| Features | 6 features | 6 features |
| States Available | 50 | 50 |
| Compounded | — | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Amazon One Medical
Amazon runs its GLP-1 business through a single unified channel here. Prescribing sits with One Medical clinicians and covers three FDA-approved drugs, Foundayo, Zepbound, and Wegovy, with nothing compounded on the list. Fulfillment is Amazon Pharmacy: same-day delivery in roughly 3,000 US cities, or pickup kiosks at select One Medical locations. Membership beforehand is not a prerequisite, and cash pay and insurance are both accepted. Foundayo launched at $25/month for patients with insurance and the Lilly Savings Card, $149/month paying cash.
Read our full Amazon One Medical review →About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →Pros & Cons
Amazon One Medical
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Amazon One Medical
- Baseline bloodwork is required before a prescription
Watch-outs
- Not included in the monthly price: medication, lab work
- Ask which pharmacy fills the prescription before you pay, so you can check its license
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Amazon One Medical wins this one, 7.1 to 6.9, above all for oral orforglipron alongside the injectables. GoodRx fits better if oral orforglipron alongside the injectables is your priority.
Choose Amazon One Medical if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Amazon One Medical vs GoodRx: FAQ
Close alternatives to Amazon One Medical and GoodRx
- Amazon One Medical vs Ro
- Amazon One Medical vs LillyDirect Foundayo
- Amazon One Medical vs Found
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.